Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher F Stratton

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Chemical Society|May 3, 2007
Evidence from Raman spectroscopy that InhA, the mycobacterial enoyl reductase, modulates the conformation of the NADH cofactor to promote catalysisAlasdair F Bell, Christopher F Stratton, Xujie Zhang, et al.
Biochemistry|March 14, 2008
Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureusHua Xu, Todd J Sullivan, Jun-ichiro Sekiguchi, et al.
Molecular Cancer Therapeutics|May 2, 2022
Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP InhibitorsLinda A Snyder, Rajendra Damle, Shefali Patel, et al.
ACS Chemical Biology|December 14, 2006
High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosisTodd J Sullivan, James J Truglio, Melissa E Boyne, et al.
Journal of Medicinal Chemistry|July 21, 2022
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical InteractionsGuozhang Xu, Zhijie Liu, Xinkang Wang, et al.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Journal of Medicinal Chemistry|April 1, 2026
Optimization of Covalent 6-Cyanoquinazoline KRAS<sup>G12C</sup> Inhibitors for the Treatment of Solid TumorsJesse P Waldo, Paul J Krawczuk, Christopher B Kelly, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Chemical Society|May 3, 2007
Evidence from Raman spectroscopy that InhA, the mycobacterial enoyl reductase, modulates the conformation of the NADH cofactor to promote catalysisAlasdair F Bell, Christopher F Stratton, Xujie Zhang, et al.
Biochemistry|March 14, 2008
Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureusHua Xu, Todd J Sullivan, Jun-ichiro Sekiguchi, et al.
Molecular Cancer Therapeutics|May 2, 2022
Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP InhibitorsLinda A Snyder, Rajendra Damle, Shefali Patel, et al.
ACS Chemical Biology|December 14, 2006
High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosisTodd J Sullivan, James J Truglio, Melissa E Boyne, et al.
Journal of Medicinal Chemistry|July 21, 2022
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical InteractionsGuozhang Xu, Zhijie Liu, Xinkang Wang, et al.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Journal of Medicinal Chemistry|April 1, 2026
Optimization of Covalent 6-Cyanoquinazoline KRAS<sup>G12C</sup> Inhibitors for the Treatment of Solid TumorsJesse P Waldo, Paul J Krawczuk, Christopher B Kelly, et al.
Pageof 2